Altamira Therapeutics Ltd. Cash Flows From Used In Operations
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Operations of -$2.25 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperations · last filed 2025-08-29
CHF
| Period end | Cash Flows From Used In Operations 6 month | Cash Flows From Used In Operations 12 month |
|---|---|---|
| 2023-12-31 | -11.51M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -7.72M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -8.68M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -5.58M CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | -13.67M CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -4.92M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | -4.84M CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | -1.63M CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | -8.39M CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | -5.25M CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | -13.23M CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -7.29M CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -24.28M CHF 20-F · filed 2020-04-16 |
USD
| Period end | Cash Flows From Used In Operations 6 month | Cash Flows From Used In Operations 6 month as first filed | Cash Flows From Used In Operations 12 month |
|---|---|---|---|
| 2025-06-30 | -$2.25M 6-K · filed 2025-08-29 | ||
| 2024-12-31 | -$6.14M 20-F · filed 2025-04-30 | ||
| 2024-06-30 | -$3.64M 6-K · filed 2025-08-29 | -$3.20M 6-K · filed 2024-09-24 | |
| 2023-12-31 | -$8.09M 20-F · filed 2025-04-30 | ||
| 2023-06-30 | -$8.43M 6-K · filed 2024-09-24 | ||
| 2022-12-31 | -$12.82M 20-F · filed 2025-04-30 |